NCT03273439 is a NA clinical trial of repetitive TMS in Schizophrenia, sponsored by Suzhou Psychiatric Hospital.

Who is sponsoring NCT03273439?

NCT03273439 is sponsored by Suzhou Psychiatric Hospital.

What drugs are being tested in NCT03273439?

Interventions in NCT03273439: repetitive TMS, Sham rTMS.

What condition does NCT03273439 study?

NCT03273439 studies Schizophrenia.

Is NCT03273439 still recruiting?

NCT03273439 is currently completed. Last updated 6 September 2017.

Last reviewed 2017-09-06 · How we verify

NCT03273439

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Study of rTMS for Cognitive Deficits in Chronic Patients With Schizophrenia

Completed NA Last updated 6 September 2017

What this trial tests

NA trial testing repetitive TMS in Schizophrenia in 47 participants. Completed in 30 June 2015.

Timeline

1 July 2012

Primary endpoint
1 February 2014

30 June 2015

Quick facts

Lead sponsor	Suzhou Psychiatric Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	47
Start date	1 July 2012
Primary completion	1 February 2014
Estimated completion	30 June 2015

Drugs / interventions tested

repetitive TMS
Sham rTMS

Conditions studied

Schizophrenia — all drugs for Schizophrenia →

Sponsor

Suzhou Psychiatric Hospital

Who can join

Adults 18 to 60, any sex, with Schizophrenia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study, we assessed the therapeutic effects and safety of left dorsolateral prefrontal cortex (DLPFC) high-frequency repetitive transcranial magnetic stimulation (rTMS) on negative symptoms of schizophrenia. We evaluated the efficacy of rTMS on cognition in patients with chronic schizophrenia.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Delayed improvements in visual memory task performance among chronic schizophrenia patients after high-frequency repetitive transcranial magnetic stimulation.
Du XD, Li Z, Yuan N, Yin M, et al · · 2022 · cited 19× · PMID 36186505 · DOI 10.5498/wjp.v12.i9.1169
Effects of varied rTMS frequencies on cognitive function in individuals with chronic schizophrenia: A double-blind randomized controlled trial.
Li J, Lu X, Du S, Hu W, et al · · 2025 · cited 3× · PMID 40479952 · DOI 10.1016/j.jpsychires.2025.05.052
Pharmacological and Mechanistic Interventions for Cognitive Impairment Associated With Schizophrenia: A Review of Registered Clinical Trials.
Peyrovian B, Palaniyappan L, Kolivakis TT, Margolese HC. · · 2026 · PMID 40908273 · DOI 10.1111/acps.70034

Verify or expand the search:

Other recruiting trials for Schizophrenia

Currently open trials in the same condition.

NCT07424404 — A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Au · Phase 3 · recruiting
NCT07467993 — Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia · Phase 2 · recruiting
NCT07379827 — Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT) · recruiting
NCT06758414 — CBT-CP for Veterans With SMI · NA · recruiting
NCT07395206 — Acceptability, Feasibility and Preliminary Outcomes of the Kiso Mind App for Outpatients With Schizophrenia Spectrum Dis · NA · recruiting

Other Suzhou Psychiatric Hospital trials

Trials by the same sponsor.

NCT03497013 — Effect of tDCS on Cognition, Symptoms in Chronic Schizophrenia Patients With Tardive Dyskinesia · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03273439 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Suzhou Psychiatric Hospital
Last refreshed: 6 September 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03273439.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing